3498 results

What is AICT-AsiaPCR?

Get a glimpse of the huge scope of this Course: its key features, a brief history, and why to be in Singapore on 23-24 October 2026!

EuroIntervention Case Reports

18 Mar 2026

The first peer-reviewed Open Access journal dedicated to interventional cardiology is now accepting submissions. Contribute to the first edition of EuroIntervention Case Reports by sharing your clinical knowledge.

Transcatheter options for degenerated surgical aortic valves - LIVE case

Recommended by PCR

08 Feb 2025 – From PCR Tokyo Valves 2025

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

Triluminate trial: how these data impact my practice

In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben, discuss the results of the Triluminate trial with David Adams and Paul Sorajja. Together they comment on the take-home messages presented during the ACC.23/WCC scientific sessions and how this...

Introducing our recognised EuroPCR Networkers!

Discover and follow the PCR Companions who have been invited to take a step further among the PCR Family -  sharing news of the Scientific Programme lined up in Paris on 20-23 May 2025, at the World-Leading Course in #interventionalcardiology.

EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...

EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

AsiaPCR/SingLIVE 2016 Programme

The 2016 edition of the Course will take place in Singapore from 21-23 January 2016. It offers a unique opportunity for the interventional community in the Asia-Pacific region to share knowledge, experience and practice in cardiovascular intervention.

Below you will find the programme breakdown and the key...

PARTNER 3 Low-Risk trial: 5-year insights on TAVI vs. SAVR outcomes

Alex Sticchi interviews Martin Leon about the five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial, presented at the #TCT23 Congress.
The analysis reveals comparable outcomes for TAVI and SAVR, with nuanced differences favouring each approach. Prof. Leon emphasizes the importance of long-term data...

Triluminate trial: deep dive into the outcomes

In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben talk with David Adams and Paul Sorajja about the first landmark trial in the field of tricuspid valve disease, Triluminate. Together they discuss the results presented during the ACC.23/WCC...

Transcatheter tricuspid valve replacement - LIVE case

Recommended by PCR

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter management of failed THV - LIVE case

Recommended by PCR

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

PCR Tricuspid Focus Group - referral meeting in Pisa

09 May 2024

Join your peers for this meeting on 22-23 September 2025 in Pisa, Italy!

Stratified treatment of INOCA: from the cathlab to the outpatient clinic

23 Mar 2021

Watch now Y. Appelman, B. De Bruyne and U. Sechtem in this series of webinars on ischemia and no obstructive coronary artery disease

PCR Valves e-Course 2020 - Exhibitor List

Discover which valued Industry Partners you will be able to interact with in the #PCRvalves virtual Exhibition on 22, 23, 24 November 2020!

The Programme is out for the PCR Fellows Course in Paris!

Dive into the newly released Programme of the PCR Fellows Course 2026. From STEMI to multivessel disease, engage with real-world patient cases, interactive sessions, and new educational features.

Introducing the #PCRvalves core team!

Discover who's behind the 3-day cross-disciplinary PCR Valves e-Course taking place on 22, 23, 24 November 2020

A Multidisciplinary Core Team

12 Jun 2025

The three Directors have different specialties: Roberto Lorusso is a cardiac surgeon, Sascha Ott a cardiac intensivist and Flavio Ribichini a interventional cardiologist. 40 other healthcare practitioners will be assigned to one of 5 working groups:

• Patient and MCS device phenotyping
• Implantation and complication management
• Shock network and patient...

PCR’s Got Talent: abstract competition

05 May 2023

EuroPCR’s abstract competition is a unique platform for practitioners to showcase their work to the international community.

Introducing the team behind PCR Tricuspid Focus Group

27 Apr 2021

Discover an overview of the new initiative’s mission and five ongoing working groups